Affimed N.V.

Good day, everyone, and welcome to AFAMED's second quarter 2023 earnings and corporate update call. As a reminder, today's conference call is being recorded. I would now like to introduce your host for today's call, Alex Soutikidis, head of investor relations at AFAMED. Please go ahead.

Thank you, Chris, and thank you all for joining us today for our second quarter 2023 update call. Before we begin, I'd like to remind everyone that we issued the relevant press release and presentation earlier today, which can be found on the investor relations section of our website. On the call today, we have the members of our management team, including our chief executive officer, Adi Hurst, Andreas Horstrich, our chief medical officer, Arantxa Tilius, our chief scientific officer, Wolfgang Fischer, our Chief Operating Officer, and Denise Mueller, our Chief Business Officer, and Angus Smith, our Chief Financial Officer. The team will be available for Q&A after the prepared remarks. Before we start, I'd like to remind everyone that today's presentation contains projections and forward-looking statements regarding future events. These statements represent our belief and assumptions as only as of the date of this call. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons why actual results could differ materially from those anticipated in the forward-looking statements, even if new information becomes available in the future. These forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in these statements due to various factors, including but not limited to those identified under the section entitled risk factors in our filings with the SEC and those identified under the section entitled forward-looking statements in the press release that we issued today and filed with the SEC. With that, I'll turn the call over to Adi. Adi?

Thank you, Alex. Good day, everyone, and thanks for joining us today.